5 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 4 with minor changes only.
Primary completion pushed from Feb 11, 2028 to May 21, 2029
Also in this update: Enrollment increased: 24 → 39 participants; Study completion pushed from May 10, 2028 to May 21, 2029
Kyowa Kirin Co., Ltd.Phase 1/2 NCT06525636 Registry history of NCT06525636 on ClinicalTrials.gov (opens the registry)
Updated
Trial completed
Also in this update: Primary completion date changed from estimate of Aug 31, 2026 to Jun 3, 2026
Kyowa Kirin Co., Ltd.Phase 2 NCT06116890 Registry history of NCT06116890 on ClinicalTrials.gov (opens the registry)
Updated
Enrollment closed, study ongoing
Also in this update: Final enrollment: 13 participants (planned 6)
Kyowa Kirin Co., Ltd.Phase 3 NCT06926491 Registry history of NCT06926491 on ClinicalTrials.gov (opens the registry)
Updated
Primary completion pushed from Aug 31, 2026 to Oct 31, 2026
Also in this update: Final enrollment: 185 participants (planned 150); Study completion pushed from Sep 30, 2026 to Nov 30, 2026
Kyowa Kirin Co., Ltd.Phase 2 NCT06116916 Registry history of NCT06116916 on ClinicalTrials.gov (opens the registry)
Updated
Trial completed
Also in this update: Final enrollment: 125 participants (planned 157); Study completion date changed from estimate of Dec 2025 to Oct 27, 2025
Kyowa Kirin Co., Ltd.Phase 1 NCT05411016 Registry history of NCT05411016 on ClinicalTrials.gov (opens the registry)
Updated
| Phase 1 | 4 | |
| Phase 1/2 | 2 | |
| Phase 2 | 3 | |
| Phase 3 | 1 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 3 | ||||
| NCT06926491 | Evaluate the Efficacy and Safety of KK8398 in Patients With Achondroplasia（AOBA Study） | Achondroplasia | Active, Not Recruiting | 2026-10-08 |
| Phase 2 | ||||
| NCT07623616 | A Phase 2 Clinical Study of Ziftomenib in Patients With Relapsed or Refractory… | Acute Myeloid Leukemia (AML) | Recruiting | 2026-06-03 |
| NCT06116916 | Study to Assess the Efficacy & Safety of KHK4951 in Patients With Diabetic Macular Edema | Diabetic Macular Edema (DME) | Active, Not Recruiting | 2026-10-14 |
| NCT04533581 | Study of ME-401 in Subjects With Relapsed or Refractory Indolent B-cell Non-Hodgkin's… | Indolent B-cell Non-Hodgkin's Lymphoma | Active, Not Recruiting | 2026-10-05 |
| Phase 1/2 | ||||
| NCT06525636 | A First-in-human Study of KK8123 in Adults With X-linked Hypophosphatemia | X-linked Hypophosphatemia | Recruiting | 2026-09-21 |
| NCT07629726 | A Phase 1/2 Study of KK2430 in Participants With Hematologic Neoplasms | Hematologic Neoplasms | Recruiting | 2026-08-07 |
| Phase 1 | ||||
| NCT06266299 | A Study of KK2269 in Adult Participants With Solid Tumors | Advanced Solid Tumor | Recruiting | 2026-09-10 |
| NCT06812104 | Phase I Clinical Trial of KK2845 in Patients With Relapsed or Refractory Acute Myeloid… | Relapsed or Refractory AML and Other Hematologic Malignancies | Recruiting | 2026-07-01 |
| NCT06823947 | Study of KK3910 in Healthy Volunteers and Patients With Essential Hypertension | Healthy Volunteers Essential Hypertension | Recruiting | 2026-07-01 |
| NCT06248411 | A Clinical Study of KK2260 in Patients With Advanced or Metastatic Solid Tumors | Advanced or Metastatic Solid Tumors | Recruiting | 2026-05-27 |
| Not specified | ||||
| NCT07132567 | Assessment of Safety and Efficacy of Poteligeo Inj. 20 mg (Mogamulizumab) Through… | Mycosis Fungoides | Recruiting | 2025-09-22 |
| NCT04870346 | Long Term Follow-up Observational Study After Clinical Trials of AMG531 (Romiplostim) in… | Aplastic Anemia | Active, Not Recruiting | 2025-09-11 |
| NCT03745521 | Study of Longitudinal Observation for Patient With X-linked Hypophosphatemic… | X-Linked Hypophosphatemia | Active, Not Recruiting | 2025-09-05 |
Acute Myeloid Leukemia (AML) (2) · Leukemia (2) · Non-Hodgkin Lymphoma (2) · Esophageal Cancer (1) · Gastric Cancer (1) · Hypertension (1) · Lung Cancer (1) · Non-Small Cell Lung Cancer (NSCLC) (1)